Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
A population of patients with unexplained neurological symptoms from six major French university hospitals was screened over a 28-month period for primary creatine disorder (PCD). Urine guanidinoacetate (GAA) and creatine:creatinine ratios were measured in a cohort of 6,353 subjects to identify PCD patients and compile their clinical,1 H-MRS, biochemical and molecular data. Six GAMT [N-guanidinoacetatemethyltransferase (EC 2.1.1.2)] and 10 X-linked creatine transporter (SLC6A8) but no AGAT (GATM) [L-arginine/glycine amidinotransferase (EC 2.1.4.1)] deficient patients were identified in this manner. Three additional affected sibs were further identified after familial inquiry (1 brother with GAMT deficiency and 2 brothers with SLC6A8 deficiency in two different families). The prevalence of PCD in this population was 0.25% (0.09% and 0.16% for GAMT and SLC6A8 deficiencies, respectively). Seven new PCD-causing mutations were discovered (2 nonsense [c.577C > T and c.289C > T] and 1 splicing [c.391 + 15G > T] mutations for the GAMT gene and, 2 missense [c.1208C > A and c.926C > A], 1 frameshift [c.930delG] and 1 splicing [c.1393-1G > A] mutations for the SLC6A8 gene). No hot spot mutations were observed in these genes, as all the mutations were distributed throughout the entire gene sequences and were essentially patient/family specific. Approximately one fifth of the mutations of SLC6A8, but not GAMT, were attributed to neo-mutation, germinal or somatic mosaicism events. The only SLC6A8-deficient female patient in our series presented with the severe phenotype usually characterizing affected male patients, an observation in agreement with recent evidence that is in support of the fact that this X-linked disorder might be more frequent than expected in the female population with intellectual disability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 8×
“7% of the creatine/phosphocreatine pool undergoes spontaneous degradation each day forming creatinine that is excreted in urine [3].”
InfluentialCreatine in humans with special reference to creatine supplementation
Balsom, P. D., Söderlund, K., & Ekblom, B. (1994) · Sports Medicine · doi:10.2165/00007256-199418040-00005 · Cited by 404 · cited 1×
“It is supplied to the body both via endogenous biosynthesis and the diet [2-4].”
Synthesis and transport of creatine in the CNS: Importance for cerebral functions
Béard, E., & Braissant, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06935.x · Cited by 192
Cerebral creatine deficiency syndromes: Clinical aspects, treatment and pathophysiology
Stockler, S., Schutz, P. W., & Salomons, G. S. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_8 · Cited by 180 · cited 3×
“However, these disorders still remain under-diagnosed whether considered together [16-20] or individually (AGAT [21-25], GAMT [26,27] or CRTR [28-33] deficiency).”
Creatine deficiency syndromes and the importance of creatine synthesis in the brain
Braissant, O., Henry, H., Béard, E., & Uldry, J. (2011) · Amino Acids · doi:10.1007/s00726-011-0852-z · Cited by 145
Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112 · cited 5×
“For additional considerations and references, the reader is kindly referred to the recent review of Olivier Braissant (Ref [14] in the text).”
InfluentialBattini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101 · cited 1×
“However, these disorders still remain under-diagnosed whether considered together [16-20] or individually (AGAT [21-25], GAMT [26,27] or CRTR [28-33] deficiency).”
Dissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes
Braissant, O., Béard, E., Torrent, C., & Henry, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.022 · Cited by 94 · cited 4×
“The brain must therefore secure most of its requirements in creatine by endogenous synthesis [10,11,13].”
InfluentialEnsenauer, R., Thiel, T., Schwab, K. O., Tacke, U., Stöckler-Ipsiroglu, S., Schulze, A., Hennig, J., & Lehnert, W. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.005 · Cited by 71 · cited 1×
“For GAMT patients, supplementation with creatine together with a GAA lowering strategy (ornithine supplementation with or without arginine restriction) may represent an efficient treatment strategy [43-46] and may provide some medical neurological benefit for GAMT patients.”
Biochemical and clinical characteristics of creatine deficiency syndromes
Sykut-Cegielska, J., Gradowska, W., Mercimek-Mahmutoglu, S., & Stöckler-Ipsiroglu, S. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3520 · Cited by 60
Cited by
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Self-citationDiagnostic methods and recommendations for the cerebral creatine deficiency syndromes
Clark, J. F., & Cecil, K. M. (2015) · Pediatric Research · doi:10.1038/pr.2014.203 · Cited by 61
“There is another study, which evaluated patients with unexplained neurological symptoms from six major French university hospitals over a 28-mo period for CCDS (19).”
BackgroundCrisafulli, D. L., Buddhadev, H. H., Brilla, L. R., Chalmers, G. R., Suprak, D. N., & San Juan, J. G. (2018) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-018-0226-y · Cited by 30
Metadata
- Authors
- Cheillan, D., Curt, M. J.-C., Briand, G., Salomons, G. S., Mention-Mulliez, K., Dobbelaere, D., Cuisset, J.-M., Lion-François, L., Portes, V. D., Chabli, A., Valayannopoulos, V., Benoist, J.-F., Pinard, J.-M., Simard, G., Douay, O., Deiva, K., Afenjar, A., Héron, D., Rivier, F., Chabrol, B., Prieur, F., Cartault, F., Pitelet, G., Goldenberg, A., Bekri, S., Gerard, M., Delorme, R., Tardieu, M., Porchet, N., Vianey-Saban, C., & Vamecq, J.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2012-12
- Volume
- 7
- Issue
- 1
- Pages
- 96-96
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2145111780
- Cited by
- 45
- References
- 11
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms. https://app.cochat.ai/papers/10.1186/1750-1172-7-96
- The paper
- Cheillan, D., Curt, M. J.-C., Briand, G., Salomons, G. S., Mention-Mulliez, K., Dobbelaere, D., Cuisset, J.-M., Lion-François, L., Portes, V. D., Chabli, A., Valayannopoulos, V., Benoist, J.-F., Pinard, J.-M., Simard, G., Douay, O., Deiva, K., Afenjar, A., Héron, D., Rivier, F., . . . Vamecq, J. (2012). Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-7-96
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.